Improving MRI for diagnosing anterior ischemic optic neuropathy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to enhance the diagnostic accuracy of diffusion-weighted imaging in detecting anterior ischemic optic neuropathy (NOIA) in patients presenting with visual disturbances. Patients over 18 years old, suspected of having NOIA, will undergo a brain and visual MRI, which will include two additional sequences specifically designed for this research. The study will assess the effectiveness of these optimized imaging techniques in improving diagnosis and patient outcomes. Participation requires informed consent and affiliation with a Social Security scheme.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient over 18 years old
* Patient with suspected NOIA, evoked after clinical examination by a specialized ophthalmologist
* For which a brain and visual MRI is planned
* Express consent to participate in the study
* Affiliate or beneficiary of a Social Security scheme

Exclusion Criteria:

* Contraindication to MRI (electrical device, metallic foreign body, claustrophobia)
* Patient benefiting from a legal protection measure
* Pregnant or breastfeeding woman

Where it's running

• Fondation A De Rothschild
  Paris, Paris, France Recruiting
• CHU de LILLE
  Lille, Lille, France Not yet recruiting
• Chu Rouen
  Rouen, France Not yet recruiting

Study contacts

• Study coordinator: Amelie YAVCHITZ
• Email: ayavchitz@for.paris
• Phone: 0148036431

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Traq device test of binocular eye function in people with and without a concussion

  This study tests the Traq device to see how well binocular eye function works in healthy people compared with people who recently had a mild-to-moderate traumatic brain injury.

  Recruiting Rebiscan, Inc. · Waukee, Iowa · NCT07742878

• Neos™ virtual-reality test for measuring eye movements and pupil responses

  This test uses a VR headset (neos™) to record where your eyes look and how your pupils react in healthy volunteers and people with eye or brain conditions.

  Recruiting at 3 sites machineMD AG · Bern, Canton of Bern and 2 other locations · NCT07258212

• French validation of the SAHOT outcome tool after subarachnoid hemorrhage

  This study tests whether a French version of the SAHOT questionnaire reliably measures outcomes in adults after subarachnoid hemorrhage.

  Recruiting Fondation Ophtalmologique Adolphe de Rothschild · Paris · NCT07894666

• Blood RNA biomarkers for ALS using neuron-derived extracellular vesicles

  This will try to see if RNA signatures in neuron-derived extracellular vesicles from blood can identify biomarkers in adults with suspected sporadic ALS compared with healthy volunteers.

  Recruiting Fondation Ophtalmologique Adolphe de Rothschild · Paris · NCT07334743

• Probenecid for cluster seizures during presurgical epilepsy monitoring

  This trial tests whether probenecid can help control clusters of seizures in people with focal epilepsy during presurgical video-EEG monitoring.

  Recruiting Phase 2 Fondation Ophtalmologique Adolphe de Rothschild · Paris and 1 other locations · NCT07318870

• Onset of myopia in children who are not yet myopic

  This study follows children aged 4 to under 9 with no myopia to see how many become nearsighted over time and what factors might influence that shift.

  Recruiting Fondation Ophtalmologique Adolphe de Rothschild · Paris · NCT07316998

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.